Hepatitis B virus X protein: TRIMming antiviral defences in hepatocytes.
Hepatitis B virus X protein: TRIMming antiviral defences in hepatocytes.
复制标题
乙型肝炎病毒 X 蛋白:修剪肝细胞中的抗病毒防御。
DOI:
10.1136/gutjnl-2017-314013
复制
发表时间:
2018
期刊:
影响因子:
24.5
通讯作者:
Thomas,Emmanuel
中科院分区:
文献类型:
--
作者:
Thomas,Emmanuel
Humans and viruses have coevolved over thousands of years; however, very few viruses are able to manifest as chronic infections with most being cleared after an acute course. Consequently, success of the human species has relied on a functional immune system that is capable of fighting off most viral pathogens. The heptatitis B virus (HBV) is one of the most successful viruses to establish chronic infection in man with over 300 million individuals currently infected worldwide and over2 billion humans having been infected by this virus. 1 These numbers underscore the tremendous ability of HBV to thwart the human immune system and establish chronic infection. In this issue of Gut, Lim et al 2 have provided evidence for a new mechanism through which HBV is able to establish and maintain chronic infection. They specifically examine the role of the enigmatic HBx protein 3 in the regulation of TRIM22, a protein that has increasingly become associated with innate antiviral responses. 4 5 Previous studies have demonstrated that HBx, a virally encoded protein that plays unusual roles in its life cycle, can correspondence to Dr Emmanuel Thomas, Schiff Center for Liver Diseases, University of Miami Miller School of Medicine, Miami, FL 33136, USA; EThomas1@ med. miami. edu on June 21, 2024 at Google Indexer. Protected by copyright. http://gut. bmj. com/